Impact of the Thrombectomy Trials on the Management and Outcome of Large Vessel Stroke: Data From the Lyon Stroke Center
Louis Viannay(Lyon 1 Université), Tae‐Hee Cho(Lyon 1 Université), Roxana Améli(Lyon 1 Université), Elodie Ong(Lyon 1 Université), Benjamin Gory(Inserm), Fannie Florin(Lyon 1 Université), Lise-Prune Berner(Hospices Civils de Lyon), Leila Chamard(Lyon 1 Université), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Julie Haesebaert(Inserm), Francis Turjman(Hôpital Pierre Wertheimer), M. Hermier(Lyon 1 Université), Yves Berthezène(Université Claude Bernard Lyon 1), Roberto Riva(Hospices Civils de Lyon), Laura Mechtouff(Hospices Civils de Lyon), Paul-Emile Labeyrie(Lyon 1 Université), Laurent Derex(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
How Does Amniotic Membrane Work?
|The Ocular Surface|2004|312
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
|The Lancet|2022|292
Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke
|Stroke|2013|282
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
|New England Journal of Medicine|2024|276